Research Topics
| James BellSummaryAffiliation: New South Wales Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatmentJames Bell
The Langton Centre, South East Sydney Illawarra Area Health Service, 591 South Dowling St, Surry Hills, NSW 2010, Australia
Addiction 104:1193-200. 2009..AIM To compare retention in treatment and mortality among people entering methadone and buprenorphine treatment for opioid dependence...
Pregnancy and injecting drug useJames Bell
National Addiction Centre, Institute of Psychiatry, London SE5 8RS
BMJ 336:1303-5. 2008
Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file reviewJames Bell
The Langton Centre, Surry Hills, New South Wales, Australia
Drug Alcohol Rev 25:167-71. 2006..05 by Kaplan - Meier test). Methadone maintenance appears to have been more effective than buprenorphine at preventing premature drop-out from treatment of adolescent heroin users...- The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxoneJames Shearer
The Langton Centre, Sydney, Australia
Drug Alcohol Rev 29:138-43. 2010..The aim of the study was to investigate the acceptability of methadone-naloxone through interviews with potential consumers and treatment providers about their attitudes and beliefs about combining methadone with naloxone... - Retention and attendance with supervised buprenorphine treatment: a case-note reviewJames Bell
The Langton Centre, Surry Hills, New South Wales, Australia
Drug Alcohol Rev 25:161-5. 2006..Participation in buprenorphine treatment often involves repeated, short episodes and erratic attendance. Measures to improve retention in treatment could improve treatment efficacy... - Estimating the risk of fatal arrhythmia in patients in methadone maintenance treatment for heroin addictionBethany Butler
University of New SouthWales, Sydney, Australia, 2 South Eastern Sydney Illawarra Health Service, Sydney, Australia
Drug Alcohol Rev 30:173-80. 2011..To estimate risk of death due to cardiac arrhythmia during methadone maintenance treatment... - The acceptability, safety, and tolerability of methadone/naloxone in a 50:1 ratioJames Bell
The Langton Centre, Sydney, Australia
Exp Clin Psychopharmacol 17:146-53. 2009..Methadone-naloxone in 50:1 ratio has the pharmacological properties to be a useful combination product for treatment of heroin addiction with reduced risk of injection... - The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependenceKristie Mammen
The Langton Centre, South Eastern Sydney and Illawarra Area Health Service, Surry Hills, NSW 2010, Australia
Expert Opin Pharmacother 10:2537-44. 2009..The development of a formulation combining buprenorphine and naloxone is designed to reduce the likelihood of intravenous misuse, and the therefore the value of the medication if diverted to the black market... - A randomized trial of effectiveness and cost-effectiveness of observed versus unobserved administration of buprenorphine-naloxone for heroin dependenceJames Bell
The Langton Centre, Surry Hills, NSW, Australia
Addiction 102:1899-907. 2007..To compare the effectiveness and cost-effectiveness of unobserved versus observed dosing of patients seeking treatment of heroin dependence... - Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002James Bell
The Langton Centre, 591 South Dowling St, Surry Hills, NSW 2010, Australia
Drug Alcohol Depend 81:55-61. 2006.... - Substitution therapy for heroin addictionJames Bell
The Langton Centre, Sydney, NSW, Australia
Subst Use Misuse 37:1149-78. 2002.... - The global diversion of pharmaceutical drugs: opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspectiveJames Bell
National Addiction Centre, Institute of Psychiatry, King s College London, London, UK
Addiction 105:1531-7. 2010..To provide a clinician's perspective on the problem of diversion of prescribed pharmaceuticals... - Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patientsBriony Larance
National Drug and Alcohol Research Centre NDARC, University of New South Wales, Sydney, Australia
Drug Alcohol Rev 30:613-20. 2011.... - A randomised, controlled trial of fluoxetine in methadone maintenance patients with depressive symptomsAngela J Dean
Department of Psychiatry, University of Queensland, Royal Hospital 4029, Brisbane, Australia
J Affect Disord 72:85-90. 2002..However, antidepressant efficacy is not well established in this population. This study examined the efficacy of fluoxetine in improving depressive symptoms and reducing substance use in MMPs... - A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawalNicholas Lintzeris
Turning Point Alcohol and Drug Centre, Fitzroy, Victoria, Australia
Addiction 97:1395-404. 2002..To determine whether buprenorphine is more effective than clonidine and other symptomatic medications in managing ambulatory heroin withdrawal... - Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductionsCourtney L Breen
National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
Drug Alcohol Depend 71:49-55. 2003..Buprenorphine is used in the treatment of opioid dependence. Due to its pharmacology, the transfer from methadone to buprenorphine may precipitate withdrawal symptoms... - Buprenorphine versus methadone maintenance: a cost-effectiveness analysisChristopher M Doran
National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Sydney, Australia
Drug Alcohol Depend 71:295-302. 2003.... - A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependenceJames Bell
The Lanston Centre, Surrey Hill, NSW, Australia
Drug Alcohol Rev 23:311-7. 2004..However, using access to unsupervised dosing to promote abstinence from heroin probably limits the potential benefits of unsupervised administration to a very small proportion of patients... - Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependenceAngela J Dean
Department of Psychiatry, University of Queensland 4029, Australia
Eur Psychiatry 19:510-3. 2004..Depressive symptoms improved in all subjects, with no difference between methadone and buprenorphine groups, suggesting no differential benefit on depressive symptoms for buprenorphine compared to methadone... - Short-term outcomes of five heroin detoxification methods in the Australian NEPOD ProjectErol Digiusto
National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
Addict Behav 30:443-56. 2005.... - Online CME: an effective alternative to face-to-face deliveryGreg Ryan
Faculty of Pharmacy, University of Sydney, NSW, Australia
Med Teach 29:e251-7. 2007..The PAC continues to be successfully delivered in face-to-face mode since 2001. From 2003 onwards, an online alternative of the PAC was also implemented...